Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

Herantis Pharma Plc ('Herantis'), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report is available ...

Security researcher Eaton was inspired to do some gentle prying of Intel websites, after considering the company's hardware ...

Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach ...

Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

Neurizon Therapeutics’ disease-modifying drug NUZ-001 has been shown to be safe and effective over 2.5 years of dosing in ...

Airtel has discontinued its ₹249 prepaid plan, following Jio’s recent move to modify its entry-level plans. The ₹249 plan was among the most popular budget-friendly packs, offering daily data, ...

They found that visceral adipose tissue volume and liver fat fraction had particularly strong relationships with ...

Base44’s no-code platform uses AI to transform ideas into apps. Create full-stack applications with ease—no coding skills ...

With rising demand and limited access to mental health care, more people are turning to AI therapy—but is it a helpful tool ...

Road safety activists and some states are pushing to depart from a norm that bases speed limits largely on how fast drivers ...

Juggling work apps, video calls, and region-locked streaming content? Split tunneling could be the VPN feature that makes ...